
Valion Bio, Inc.
VBIOHealthcare|Biotechnology|US
$0.51
+0.01 (+1.57%)
DCF Value
$5.14
Tangible Book / Share
$45.75
Cash / Share
$15.59
Next Earnings Report
Nov 13, 2026
Financing Filings (last 12 months)
12
Shelf registrations / offering prospectuses — latest Oct 21, 2026 (424B3). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Valion Bio's New Leadership Unveils 30-Day Agenda to Accelerate Clinical Pipeline and Unlock Shareholder Value
Oct 21, 2026 · Accesswire
Valion Bio's Next-Generation NMR Partnership with LarmorBio Delivers Initial Feasibility Milestone
Oct 15, 2026 · Accesswire
With Section 232 Tariffs Reshaping Biotech, Valion Bio's Velocity Bioworks Capitalizes on Domestic CDMO Surge
Oct 14, 2026 · Accesswire
New Valion Bio Board Chair Thomas Jensen Brings Biotech Turnaround Experience to the Advancement of Entolimod
Oct 5, 2026 · Accesswire
Valion Bio and Shear Kershman Laboratories Successfully Formulate Oral Mucosal Entolimod; Valion Sees Potential for Multi-Fold Expansion of Long-Term Opportunity
Sep 30, 2026 · Accesswire
Valion Appoints Life Sciences Veteran Dean Zikria as Interim CEO and Announces Board Leadership Transitions
Sep 23, 2026 · Accesswire
Valion Bio Regains Compliance with NASDAQ Minimum Bid Price Listing Rule
Sep 22, 2026 · Accesswire
Valion Bio Announces Changes to Management and Board of Directors
Sep 1, 2026 · Accesswire
Valion Bio Announces Reverse Stock Split
Aug 27, 2026 · Accesswire
SEC Filings (151)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 5, 2026 | 8-K | Material event | DocumentIndex |
| Nov 2, 2026 | 8-K | Material event | DocumentIndex |
| Oct 29, 2026 | 8-K | Material event | DocumentIndex |
| Oct 27, 2026 | 8-K | Material event | DocumentIndex |
| Oct 26, 2026 | 8-K | Material event | DocumentIndex |
| Oct 22, 2026 | 8-K | Material event | DocumentIndex |
| Oct 21, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Oct 20, 2026 | EFFECT | DocumentIndex | |
| Oct 20, 2026 | EFFECT | DocumentIndex | |
| Oct 16, 2026 | S-3 | Shelf registration | DocumentIndex |
| Oct 16, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Oct 15, 2026 | 8-K | Material event | DocumentIndex |
| Oct 14, 2026 | 8-K | Material event | DocumentIndex |
| Oct 8, 2026 | 8-K | Material event | DocumentIndex |
| Oct 8, 2026 | S-3 | Shelf registration | DocumentIndex |
| Oct 6, 2026 | 8-K | Material event | DocumentIndex |
| Oct 2, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Oct 1, 2026 | 8-K | Material event | DocumentIndex |
| Sep 23, 2026 | 8-K | Material event | DocumentIndex |
| Sep 4, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Sep 3, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Sep 2, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Sep 1, 2026 | 8-K | Material event | DocumentIndex |
| Aug 27, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Aug 27, 2026 | 8-K | Material event | DocumentIndex |
| Aug 24, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Aug 24, 2026 | RW | DocumentIndex | |
| Aug 20, 2026 | 8-K/A | Material event | DocumentIndex |
| Aug 19, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Aug 17, 2026 | 8-K | Material event | DocumentIndex |
| Aug 14, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Aug 14, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 12, 2026 | EFFECT | DocumentIndex | |
| Aug 11, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Aug 6, 2026 | 8-K | Material event | DocumentIndex |
| Aug 3, 2026 | SC 13D | Activist / 5%+ stake | DocumentIndex |
| Jul 17, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Jul 17, 2026 | S-1 | IPO / offering registration | DocumentIndex |
| Jul 17, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jul 14, 2026 | 8-K | Material event | DocumentIndex |